D-0605-2020 Class II Terminated

Recalled by Coast Quality Pharmacy, LLC Dba Anazao Health — Tampa, FL

FDA drug recall D-0605-2020 was initiated by Coast Quality Pharmacy, LLC Dba Anazao Health on Sep 3, 2019 and is designated Class II. Reason for recall: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. The recall status is terminated (terminated Dec 1, 2020).

Recall details

Product Type
Drugs
Report Date
Dec 18, 2019
Initiation Date
Sep 3, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Fentanyl Citrate and Clonidine HCL and Morphine Sulfate and Baclofen in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.

Reason for recall

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Distribution pattern

Nationwide in the U.S.

Code information

All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0605-2020
openFDA file date
Nov 17, 2026
Loaded by RegDataLab
Nov 18, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0605-2020. Report a data issue: hello@regdatalab.com.